Fig. 5From: Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary diseaseTreatment outcomes of ICIs in spirometry-defined COPD patients with and without CIP. Kaplan-Meier curve of (a) progression-free survival and (b) overall survival. Abbreviations: COPD, chronic obstructive pulmonary disease; ICI, immune checkpoint inhibitorBack to article page